| Title: | Reversible Cancer Therapeutics-related Cardiac Dysfunction Complicating Intra-cardiac Thrombi |
| Authors: | Tsujinaga, Shingo Browse this author →KAKEN DB |
| Iwano, Hiroyuki Browse this author →KAKEN DB |
| Oshino, Tomohiro Browse this author |
| Kadosaka, Takahide Browse this author |
| Mizuguchi, Yoshifumi Browse this author |
| Motoi, Ko Browse this author |
| Chiba, Yasuyuki Browse this author |
| Koya, Taro Browse this author |
| Temma, Taro Browse this author |
| Kamiya, Kiwamu Browse this author →KAKEN DB |
| Fukushima, Arata Browse this author →KAKEN DB |
| Koizumi, Takuya Browse this author |
| Sato, Tomoya Browse this author |
| Takenaka, Sakae Browse this author |
| Tada, Atsushi Browse this author |
| Ishizaka, Suguru Browse this author |
| Sarashina, Miwa Browse this author |
| Omote, Kazunori Browse this author →KAKEN DB |
| Kamada, Rui Browse this author →KAKEN DB |
| Konishi, Takao Browse this author |
| Sato, Takuma Browse this author |
| Nagai, Toshiyuki Browse this author →KAKEN DB |
| Yamashita, Hiroko Browse this author →KAKEN DB |
| Anzai, Toshihisa Browse this author →KAKEN DB |
| Keywords: | epirubicin |
| bevacizumab |
| cardiotoxicity |
| heart failure |
| thrombus |
| Issue Date: | 2020 |
| Publisher: | 日本内科学会(The Japanese Society of Internal Medicine) |
| Journal Title: | Internal medicine |
| Volume: | 59 |
| Issue: | 17 |
| Start Page: | 2155 |
| End Page: | 2160 |
| Publisher DOI: | 10.2169/internalmedicine.4792-20 |
| Abstract: | Epirubicin-based chemotherapy carries a risk of inducing heart failure, although the frequency is rare. Bevacizumab, an anti-vascular endothelial growth factor monoclonal antibody, has recently been widely used in patients with recurrent breast cancer as a first-line chemotherapeutic agent. Heart failure or arterial thromboembolism has been reported as a rare cardiovascular complication of bevacizumab. We herein report a breast cancer patient with reversible cancer therapeutics-related cardiac dysfunction associated with bevacizumab and epirubicin complicating intracardiac thrombi in the left atrium and left ventricle. This case underscores the importance of tailored medical planning according to the individual status in patients receiving anti-cancer therapies. |
| Rights: | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| Type: | article |
| URI: | http://hdl.handle.net/2115/79587 |
| Appears in Collections: | 医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
